MedTrace Logo

Intravenous Heparin as an Adjunct for the Treatment of Anaphylactic Reactions in an Emergency Department

NCT00657228 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-01-09

No results posted yet for this study

Summary

To determine if intravenous unfractionated heparin (with standard therapy) for treatment of anaphylaxis results in faster time to recovery.

Conditions

Interventions

DRUG

Intravenous heparin

Intravenous heparin as an adjunct for the treatment of anaphylactic/anaphylactoid reactions in the Emergency Department. To determine if a single bolus of intravenous unfractionated heparin (in conjunction with standard therapy) given to patients with anaphylactic/anaphylactoid reactions results in a faster time to recovery when compared to standard therapy alone.

DRUG

Saline

Standard treatment (epinephrine, corticosteroids, diphenhydramine, and H2 blockers) and saline.

Sponsors & Collaborators

  • Truman Medical Center

    collaborator OTHER

  • Saint Luke's Hospital

    collaborator UNKNOWN

  • Emergency Physicians Foundation of KC

    collaborator UNKNOWN

  • American College of Emergency Physicians

    collaborator OTHER

  • University of Missouri, Kansas City

    lead OTHER

Principal Investigators

  • Ryan Jacobsen, MD · Truman Medical Center

  • Stefanie Ellison, MD · Truman Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00657228 on ClinicalTrials.gov